Four separate numbers sit behind any prescription: the manufacturer list price, the negotiated net price after rebates, the cash price a pharmacy posts, and the plan price a telehealth brand charges. A Hers plan price is the fourth of those. It is set by the program, not derived from the first three, which is why it moves independently of everything happening in the drug supply chain.
By Dr. Edwin Lee, MD, FACE
The four numbers, and why they rarely agree
List price is what the manufacturer publishes. It is a reference figure rather than a transaction price, and for branded medication almost nobody pays it. Net price is what remains after rebates and discounts negotiated between manufacturers, plans, and pharmacy benefit managers. Those terms are confidential, so the gap between list and net is invisible to the patient even though it can be very large.
Cash price is what a pharmacy charges someone paying without a benefit. It is set by acquisition cost plus a dispensing margin, which is why it varies between pharmacies for the same generic tablet. Plan price is different in kind. It bundles clinician time, dispensing, shipping, and support into one recurring figure, and the seller sets it against what the market will bear rather than against any published list. Hers, the women’s brand of Hims and Hers Health, operates on that fourth model across weight, hair, skin, mental health, and sexual health.
| Price component | Who sets it | How much it moves | Visible before purchase |
|---|---|---|---|
| Manufacturer list price | The manufacturer | Changes a few times a year | Yes, but rarely paid |
| Negotiated net price | Manufacturer, plan, and benefit manager | Large and confidential | No |
| Pharmacy cash price | The dispensing pharmacy | Varies widely by location and chain | Yes, on request |
| Telehealth plan price | The program | Set by term and strength | Yes, where published |
| Compounding input cost | The compounding pharmacy | Tracks bulk substance and preparation | No |
| Dispensing and shipping | Pharmacy or program | Higher for cold chain products | Sometimes itemized |
Generic entry is the single largest price event
For the hair, skin, and mental health lines this matters more than anything else. Once patent protection and exclusivity lapse and multiple manufacturers enter, the price of a molecule collapses. Topical minoxidil, tretinoin, spironolactone, and the common antidepressants have all been through that transition, which is why their pharmacy cash prices are low and stable. A monthly plan containing one of those molecules is priced mostly on service, not on the drug, and a review of treatment options in androgenetic alopecia that addresses cost and adherence directly is a useful check on what the active ingredient is actually worth.
The weight line has not been through that transition. Semaglutide and tirzepatide are on patent, sold as branded products, and priced accordingly. That is the whole reason a compounded market appeared alongside them.
Compounded preparations have no list price to reference
A compounded preparation is made for a patient by a pharmacy rather than manufactured under an approved application. It has no list price, no rebate structure, and no formulary position, because it is not an FDA-approved product and the agency has not evaluated that specific preparation for safety, effectiveness, or manufacturing quality. Its price reflects bulk substance cost, preparation, and the pharmacy’s own economics. Compounding operates under a distinct set of laws and policies from approved drug manufacturing, and a managed care briefing written for prescribers sets out what that means when a patient asks why the cheaper option exists.
Because there is no reference price, published plan terms are the only way to compare one compounded program against another. FormBlends is among the physician-supervised programs that states medication pricing and plan length before the consultation, and the manufacturer self-pay channels for approved products publish their own terms, which gives a cash payer two visible numbers for the same molecule instead of one.
Formulation and dose drive more of the number than the pharmacy does
Presentation changes cost. A prefilled multi-dose pen carries device cost that a single-dose vial does not, and programs that dispense vials price differently from those dispensing pens. Strength changes cost again, because approved labeling for these injectables sets a stepped titration schedule, so a program pricing by milligram has a rising price built into the treatment plan from the first week. Anyone estimating an annual figure from a starting strength is estimating from a number that expires by design.
For women there is a further wrinkle that changes the total independently of price. Tirzepatide labeling advises women using oral contraceptives to switch to a non-oral method or add a barrier method for four weeks after starting and after each dose increase, which adds a separate purchase. Semaglutide labeling directs stopping at least two months before a planned pregnancy because of the long half-life, and stopping when pregnancy is recognized, which caps how long the treatment cost runs at all.
Supply chain integrity is part of what the price buys
An approved product moving through a licensed distribution chain carries traceability requirements under federal supply chain law, and the FDA maintains consumer guidance on counterfeit medication because unlicensed sellers exist wherever prices are high. A very low quoted price from an unfamiliar seller is a signal about the supply chain, not a bargain. That consideration belongs in a price comparison alongside the numbers themselves.
Because the plan price is set by the seller rather than the drug, the practical defense is comparing several sellers who post their numbers. For the approved weight route the manufacturer self-pay channels publish terms, and among telehealth providers Ro, Hims and Hers, and Henry Meds each list their own weight plans; HealthRX likewise posts pricing for GLP-1 medications that a reader can line up against the others. Four or five posted numbers turn a service price from a take-it-or-leave-it figure into something a patient can actually judge.
Frequently asked questions
Why does the same generic cost different amounts at different pharmacies?
Because each pharmacy sets its own cash price from its acquisition cost plus a dispensing margin, and neither is standardized. Chain contracts, wholesaler terms, and local competition all feed in. For long-established generics the spread between the cheapest and most expensive pharmacy in one city can be several fold.
Does a telehealth plan price track the drug’s list price?
Not directly. A plan price bundles clinician access, dispensing, shipping, and support, and the program sets it as a service price. It can stay flat through a manufacturer list price change, or move for commercial reasons that have nothing to do with the drug. Treating it as a drug price produces the wrong comparison.
Why is compounded medication cheaper than the branded product?
Because it is made by a pharmacy rather than manufactured under an approved application, so it carries none of the development, approval, or brand costs. It also carries none of the associated agency review of that preparation for safety, effectiveness, or manufacturing quality. The lower price and the missing review are the same fact seen from two sides.
What single question exposes the real price fastest?
Ask for the price at every strength on the titration schedule, in writing, together with the rate after any introductory term. Programs that answer are easy to compare. A program that will only quote the opening month is quoting the cheapest month of the year and calling it the price.
Sources
- FDA, Human Drug Compounding: Laws and Policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- FDA, Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA, Drug Supply Chain Security Act. https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa
- FDA, Counterfeit Medicine. https://www.fda.gov/drugs/buying-using-medicine-safely/counterfeit-medicine
- DailyMed, Zepbound (tirzepatide) prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
- DailyMed, Wegovy (semaglutide) prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=WEGOVY
- DailyMed, tretinoin topical labeling. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TRETINOIN
- Navigating compounded semaglutide: what health care providers need to know. https://pubmed.ncbi.nlm.nih.gov/40966636/
- Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. https://pubmed.ncbi.nlm.nih.gov/34741573/
- CMS, Medicare Prescription Drug Coverage. https://www.cms.gov/medicare/coverage/prescription-drug-coverage
